Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegaptanib Sodium in Diabetic Macular Edema
NCT01189461Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2011
- Primary completion
- Jul 2012
- Modality
- Antisense DNA, RNA Aptamers, Small Interfering RNA (siRNA)
- Countries
- 4
01
Overview
A Phase 3 trial of pegaptanib sodium in diabetic macular edema (DME), sponsored by Pfizer. Started Jan 2011; status: completed.
02
Drugs
pegaptanib sodium
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01189461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01189461.